Back to news

Palvella Therapeutics to Host Webcast to Introduce New QTORIN™ Program

Globe Newswire•18/11/2026•17:00 ET
0

Key Highlights

  • ➤Third QTORIN™ platform product candidate to be announced tomorrow
  • ➤Live webcast scheduled November 19, 2026, at 8:30 a.m. ET
  • ➤QTORIN™ rapamycin targets three rare vascular and skin conditions
  • ➤QTORIN™ pitavastatin targets disseminated superficial actinic porokeratosis

Third product candidate from Palvella’s QTORIN™ platform to be announced

Live audiovisual webcast to take place tomorrow, Thursday, November 19, 2026, at 8:30 a.m. ET

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in